Dinesh Kashyap

Dinesh Kashyap

FDA Chooses Box for Cloud Content Management1 min read

The U.S. Food and Drug Administration (FDA) has reportedly selected Box’s cloud content management platform to modernize its technical infrastructure and drive new ways to work in the cloud. With Box, the FDA is furthering its IT innovation strategy to digitize business processes and envision new ways to engage with the pharmaceutical and life sciences industry.

FDA IT leadership, tasked with modernizing its technology infrastructure and re-imagining how the FDA works with the life sciences industry, selected Box to:

• Improve external collaboration with third party organizations, including external experts, and supporting audits, discoveries and reviews;
• Digitize and automate processes leveraging Box as a central content portal where staff can easily collaborate and share materials internally and with external parties;
• Reduce complexity of infrastructure by eliminating fragmented content and document management tools; and
• Provide the FDA with added cybersecurity control and administrative capabilities necessary to govern and protect sensitive information at scale.
Cloudbyz has built electronic trial master file (eTMF) to collaborate in clinical research between sponsors, CRO and clinical sites. Cloudbyz eTMF leverages Box to store content. Cloudbyz eTMF creates TMF folder structure with button and enables better organization of content as per DIA TMF structure.

Credit: clinical informatics news

SHARE THIS POST

LinkedIn
Twitter
Facebook

Related Blog​s

CTMS
Srinivas Sashidhar K

5 Things to Consider to Choose the Right CTMS

A number of solutions are being built to manage day-to-day clinical trial activities. Most solution providers in the market claim to have a complete CTMS solution, however, not all solutions have end-to-end features. A checklist for systematic assessment of the available CTMS solutions prior to investment is essential.
Most importantly, CTMS will be used to manage sensitive medical data

Read More »
CTMS
Srinivas Sashidhar K

Artificial Intelligence – Critical Prerequisite of Clinical Trials

A vast majority of researchers and specialized tech startup companies have started investing in developing Big Data and Artificial Intelligence (AI) tools to serve the pharmaceutical and medical devices companies, which is believed to transform the clinical trial process. But what exactly is the main outcome of AI?The buzz around AI

Read More »
CTMS
Mythri Raghunandan

Verily’s Project Baseline is Modernizing Clinical Trials

Verily, a subsidiary of Alphabet inc. and the sister company of Google Inc. has initiated Project Baseline, with the aim to leverage the collaboration of clinical research and clinical care providers to develop proactive healthcare tools and services. Verily is partnered with Pfizer,  Sanofi,  Novartis and Otsuka to explore the opportunities in cardiovascular disease, oncology, mental health, dermatology, and diabetes.

Read More »

©2020 Cloudbyz Inc. All Rights Reserved.